Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.
Press releases published on May 8, 2025

Metsera to Present at Bank of America 2025 Global Healthcare Conference
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit …

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
1Q25 Total Product Revenue of $49.3M FY25 Total Product Revenue Guidance Revised to $250M-$300M FY25 Operating Expenses Reduced and 2H26 Cash Runway Guidance Maintained 2025 Regulatory Approvals for Amtagvi® Expected in the UK, EU, and Canada On Track to …

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
– Generated Q1’25 Quarterly Net Revenue of $177.8 Million, Up 23% Year-over-Year – – Grew Jornay PM® Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million; Jornay PM Prescribers Reached an All-Time-High – – Completed …

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Topline data from multiple Phase 2 studies expected throughout 2025 • Q2 readout from VTX3232 study in patients with early Parkinson’s disease • H2 readout from VTX2735 study in patients with recurrent pericarditis • H2 readout from VTX3232 study in …

Colliers adds top-tier firm to Canadian engineering platform
TORONTO and CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Colliers (NASDAQ, TSX: CIGI) announced today that its Canadian engineering platform Englobe Corporation (“Englobe”) has acquired Higher Ground Consulting Inc. (“Higher Ground”), a leading …

First Quantum Minerals Announces Voting Results for the Election of Directors
TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) announced that the nominees listed in the Management Information Circular for the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) …

Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in CIndU …

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH- …

Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today
WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and …

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter …

Teknova Reports First Quarter 2025 Financial Results
First quarter 2025 total revenue was $9.8 million, up 5% from prior year Company introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc. Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., …

Skye Bioscience Reports First Quarter 2025 Results and Highlights Nimacimab Differentiation in Obesity
Nimacimab in combination with tirzepatide improves weight loss effect over tirzepatide alone, and shows comparable weight loss to monlunabant and tirzepatide alone in preclinical diet-induced obesity model In vitro data reported from new preclinical study …

Serve Robotics Announces First Quarter 2025 Results
Successfully built and deployed 250 new third-generation robots, enhancing operational scale and efficiency Continued geographic expansion into Miami and Dallas metros; Atlanta launch on track First quarter revenue of $440 thousand, a 150% increase versus …

EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

DLH to Continue Providing R&D and Advanced Technology Services to the Telemedicine and Advanced Technology Research Center
ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security, today …

IBTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ibotta, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz …

Jushi Holdings Inc. Reports First Quarter 2025 Financial Results
Retail-First Growth Strategy Continues with 40 Operational Locations Nationwide at Quarter-End and Five Additional Stores Expected to Open by Year-End Strengthened Balance Sheet Through Strategic Transactions to Support Continued Expansion Net Loss of $17. …

Clearfield Reports Second Quarter Fiscal 2025 Results
Company returns to profitability, generating net income per diluted share of $0.09 Revenue of $47.2 million driven by 47% year-over-year growth in the Clearfield Segment Company focused on executing to opportunity, yet economic uncertainty leads the …